These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 32799384)

  • 1. Unhealthy lifestyle habits and physical inactivity among Asian patients with non-alcoholic fatty liver disease.
    Zhang X; Goh GB; Chan WK; Wong GL; Fan JG; Seto WK; Huang YH; Lin HC; Lee IC; Lee HW; Kim SU; Chow WC; Wong VW
    Liver Int; 2020 Nov; 40(11):2719-2731. PubMed ID: 32799384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modelling NAFLD disease burden in four Asian regions-2019-2030.
    Estes C; Chan HLY; Chien RN; Chuang WL; Fung J; Goh GB; Hu TH; Huang JF; Jang BK; Jun DW; Kao JH; Lee JW; Lin HC; Razavi-Shearer K; Seto WK; Wong GL; Wong VW; Razavi H
    Aliment Pharmacol Ther; 2020 Apr; 51(8):801-811. PubMed ID: 32133676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of factors associated with physical inactivity among East Asian college students.
    Seo DC; Torabi MR; Chin MK; Huang SF; Chen CK; Mok MM; Wong P; Chia M; Lee CG; Wang C
    Int J Behav Med; 2012 Sep; 19(3):316-23. PubMed ID: 21562780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial.
    Katsagoni CN; Papatheodoridis GV; Ioannidou P; Deutsch M; Alexopoulou A; Papadopoulos N; Papageorgiou MV; Fragopoulou E; Kontogianni MD
    Br J Nutr; 2018 Jul; 120(2):164-175. PubMed ID: 29947322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of non-alcoholic fatty liver disease in Hong Kong: a population study with paired proton-magnetic resonance spectroscopy.
    Wong VW; Wong GL; Yeung DK; Lau TK; Chan CK; Chim AM; Abrigo JM; Chan RS; Woo J; Tse YK; Chu WC; Chan HL
    J Hepatol; 2015 Jan; 62(1):182-9. PubMed ID: 25195550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of illness perception and self-efficacy in lifestyle modification among non-alcoholic fatty liver disease patients.
    Zelber-Sagi S; Bord S; Dror-Lavi G; Smith ML; Towne SD; Buch A; Webb M; Yeshua H; Nimer A; Shibolet O
    World J Gastroenterol; 2017 Mar; 23(10):1881-1890. PubMed ID: 28348495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. When the liver gets stiff, the tough get moving.
    Nguyen TH; Wardell R; Chitturi S; Teoh N; Farrell G
    J Gastroenterol Hepatol; 2020 Jun; 35(6):953-959. PubMed ID: 31867782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography.
    Wong VW; Chu WC; Wong GL; Chan RS; Chim AM; Ong A; Yeung DK; Yiu KK; Chu SH; Woo J; Chan FK; Chan HL
    Gut; 2012 Mar; 61(3):409-15. PubMed ID: 21846782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study.
    Kwok R; Choi KC; Wong GL; Zhang Y; Chan HL; Luk AO; Shu SS; Chan AW; Yeung MW; Chan JC; Kong AP; Wong VW
    Gut; 2016 Aug; 65(8):1359-68. PubMed ID: 25873639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus using transient elastography.
    Lai LL; Wan Yusoff WNI; Vethakkan SR; Nik Mustapha NR; Mahadeva S; Chan WK
    J Gastroenterol Hepatol; 2019 Aug; 34(8):1396-1403. PubMed ID: 30551263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of controlled attenuation parameter and liver stiffness measurement for detecting increased arterial stiffness in asymptomatic populations in China.
    Yu XY; Song XX; Tong YL; Wu LY; Song ZY
    Medicine (Baltimore); 2020 Nov; 99(48):e23360. PubMed ID: 33235107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and Severity of Nonalcoholic Fatty Liver Disease in Non-Obese Patients: A Population Study Using Proton-Magnetic Resonance Spectroscopy.
    Wei JL; Leung JC; Loong TC; Wong GL; Yeung DK; Chan RS; Chan HL; Chim AM; Woo J; Chu WC; Wong VW
    Am J Gastroenterol; 2015 Sep; 110(9):1306-14; quiz 1315. PubMed ID: 26215532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A "healthy diet-optimal sleep" lifestyle pattern is inversely associated with liver stiffness and insulin resistance in patients with nonalcoholic fatty liver disease.
    Katsagoni CN; Papatheodoridis GV; Papageorgiou MV; Ioannidou P; Deutsch M; Alexopoulou A; Papadopoulos N; Fragopoulou E; Kontogianni MD
    Appl Physiol Nutr Metab; 2017 Mar; 42(3):250-256. PubMed ID: 28133993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study.
    Newsome PN; Sasso M; Deeks JJ; Paredes A; Boursier J; Chan WK; Yilmaz Y; Czernichow S; Zheng MH; Wong VW; Allison M; Tsochatzis E; Anstee QM; Sheridan DA; Eddowes PJ; Guha IN; Cobbold JF; Paradis V; Bedossa P; Miette V; Fournier-Poizat C; Sandrin L; Harrison SA
    Lancet Gastroenterol Hepatol; 2020 Apr; 5(4):362-373. PubMed ID: 32027858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coffee and tea consumption in relation with non-alcoholic fatty liver and metabolic syndrome: A systematic review and meta-analysis of observational studies.
    Marventano S; Salomone F; Godos J; Pluchinotta F; Del Rio D; Mistretta A; Grosso G
    Clin Nutr; 2016 Dec; 35(6):1269-1281. PubMed ID: 27060021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between coffee consumption, sleep duration and smoking status with elastographic parameters of liver steatosis and fibrosis; controlled attenuation parameter and liver stiffness measurements.
    Mikolasevic I; Domislovic V; Filipec Kanizaj T; Radic-Kristo D; Krznaric Z; Milovanovic T; Juric T; Klapan M; Skenderevic N; Delija B; Stevanovic T; Mijic A; Lukic A; Stimac D
    Int J Clin Pract; 2021 Mar; 75(3):e13770. PubMed ID: 33070425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations Between Lifestyle Characteristics and the Presence of Nonalcoholic Fatty Liver Disease: A Case-Control Study.
    Katsagoni CN; Georgoulis M; Papatheodoridis GV; Fragopoulou E; Ioannidou P; Papageorgiou M; Alexopoulou A; Papadopoulos N; Deutsch M; Kontogianni MD
    Metab Syndr Relat Disord; 2017 Mar; 15(2):72-79. PubMed ID: 27869531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular risk profiles and outcomes of Chinese living inside and outside China.
    Chiu JF; Bell AD; Herman RJ; Hill MD; Stewart JA; Cohen EA; Liau CS; Steg PG; Bhatt DL;
    Eur J Cardiovasc Prev Rehabil; 2010 Dec; 17(6):668-75. PubMed ID: 20431393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coffee Intake Is Associated with a Lower Liver Stiffness in Patients with Non-Alcoholic Fatty Liver Disease, Hepatitis C, and Hepatitis B.
    Hodge A; Lim S; Goh E; Wong O; Marsh P; Knight V; Sievert W; de Courten B
    Nutrients; 2017 Jan; 9(1):. PubMed ID: 28075394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations between dietary habits and risk factors for cardiovascular diseases in a Hong Kong Chinese working population--the "Better Health for Better Hong Kong" (BHBHK) health promotion campaign.
    Ko GT; Chan JC; Tong SD; Chan AW; Wong PT; Hui SS; Kwok R; Chan CL
    Asia Pac J Clin Nutr; 2007; 16(4):757-65. PubMed ID: 18042539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.